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ABSTRACT 20 
The aim of this survey is to explore the possible effects of unsupported (CuNPs) and 21 
supported copper nanoparticles (CuNPs/support) of different morphologies on basic ovarian 22 
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cell functions. For this purpose, we have compared the activity of unsupported spherical, 23 
triangular and hexagonal CuNPs, as well as of spherical CuNPs supported on titania, zeolite Y 24 
and activated charcoal (0, 1, 10 or 100 ng/mL) on cultured porcine ovarian granulosa cells. 25 
Cell viability, proliferation (accumulation of proliferating cell nuclear antigen, PCNA), 26 
apoptosis (accumulation of Bcl-2-associated X protein, bax) and release of steroid hormones 27 
progesterone, testosterone and 17β-estradiol have been analyzed by the Trypan blue test, 28 
quantitative immunocytochemistry and ELISA, respectively. Cell viability decreased after 29 
treatment with hexagonal CuNPs, whilst all the other CuNPs increased it. Unsupported 30 
spherical and hexagonal CuNPs, and spherical CuNPs/titania reduced PCNA accumulation; in 31 
contrast, an increase was noted for unsupported triangular CuNPs and CuNPs/zeolite Y. Bax 32 
accumulation was not affected by hexagonal CuNPs, whereas CuNPs/zeolite Y promoted it 33 
and all the other CuNPs depleted it. The release of all steroid hormones was inhibited by 34 
CuNPs/TiO2 and stimulated by CuNPs/charcoal, whilst CuNPs/zeolite Y promoted the 35 
testosterone and 17β-estradiol output, but not that of progesterone. 36 
These results demonstrate the direct, mainly stimulatory, impact of CuNPs on basic ovarian 37 
cell functions. The character of the CuNPs’ action depends on their shape and support. 38 
Therefore, CuNPs with appropriate chemical modification could be potentially useful for the 39 
control of reproductive processes and treatment of reproductive disorders. 40 
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1. INTRODUCTION 44 
In the recent past, nanotechnology and the application of nano-metals (metal particles less 45 
than 100 nm size) have experienced a high growth rate (Kumar, 2009; Reddy et al., 2012; 46 
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Stark et al., 2015, Bhagyaraj et al., 2018). Copper nanoparticles (CuNPs) have shown a lot of 47 
promise as drugs for the treatment of osteoporosis, antibacterial and antifungal agents, 48 
contraceptives, in cancer imaging and therapy, and as farm animal food additives (Zhou et al., 49 
2016; Rathore et al, 2018; Verma et al., 2019). They are used as fluorescent gas sensors, drug 50 
carriers, additives in lubricants, coatings for plastics, in catalysis and in other modern 51 
technologies (Gawande et al., 2016). Nevertheless, their application can be hampered by their 52 
toxicity for various living organisms (Hejazy et al., 2018; Ameh et al., 2019). For instance, it 53 
has been reported that CuNPs are toxic to fish, in some cases with comparable adverse effects 54 
to those of dissolved copper (Shaw et al., 2012; Al-Bairuty et al., 2013; Hedayati et al. 2016; 55 
Hoseini et al., 2016). Copper is a necessary co-factor for of a wide array of metabolic 56 
enzymes related to immune reactions, metabolism of neuromodulators, proteins and lipids 57 
(Pohanka, 2018). On the other hand, the adverse consequences of CuNPs on liver, spleen, 58 
kidney, respiratory system, neurons and DNA, which can induce cancer, have been well 59 
documented (Hejazy et al., 2018; Pohanka, 2019). The cyto- and genotoxic properties of 60 
CuNPs are mainly explained by their ability to produce reactive oxygen species, which induce 61 
both nuclear and cytoplasmic apoptosis (Roychoudhury et al., 2016; Hou et al., 2017; Ameh 62 
et al., 2019; Pohanka, 2019). In addition, the toxic impact of CuNPs can be due to their 63 
capacity to damage nuclear membranes, to act upon Ca2+ channels, nuclear factor kappa-light-64 
chain-enhancer of activated B cells (NFkB) inflammatory transcription factor and mitogen-65 
activated protein kinase which, in turn, are involved in DNA synthesis and damage (Hou et 66 
al., 2017). 67 
The available data concerning copper and CuNPs’ action on reproduction remain insufficient 68 
and contradictory. A body of evidence obtained on rodents demonstrated the capability of 69 
both copper and CuNPs to reduce gonadotropin and blood gonadal steroid hormones levels, to 70 
induce degenerative changes in gonads, ovarian follicular atresia, and to suppress gamete and 71 
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embryogenesis (Roychoudhury et al., 2016; Yang et al., 2017; Zhang et al., 2018). These 72 
adverse results could be related to the facility of CuNPs to suppress anti-oxidative enzymes 73 
and to induce ovarian cell apoptosis (Yang et al., 2017). Other studies, however, did not find 74 
any adverse effect of CuNPs on the number of mice ovarian follicles (Roychoudhury et al., 75 
2016) and pregnancy (Zhang et al., 2018). Finally, some experiments revealed a stimulatory 76 
role of copper on porcine pituitary gonadotropin secretion (Roychoudhury et al., 2016), 77 
ovulation rate (Fevold et al., 1936), release of insulin-like growth factor I (IGF-I) and 78 
progesterone, and accumulation of both proliferation and suppressed apoptosis in cultured 79 
granulosa cells (Roychoudhury et al., 2014, 2016). Therefore, the available literature 80 
illustrates either positive or adverse behavior of copper or CuNPs on reproduction. This 81 
behavior could be mediated by pituitary gonadotropins, ovarian steroid hormones, and IGF-I 82 
and regulators/markers of both ovarian cell proliferation and apoptosis. Nonetheless, the 83 
reports concerning the characteristics of this activity on ovarian cells remain contradictory, 84 
and its elucidation and factors defining the type of the CuNPs’ performance on the ovary 85 
require further studies. 86 
The application of CuNPs and the production of safe CuNPs require understanding the factors 87 
influencing their outcome on physiological processes, including reproduction. The 88 
morphology of CuNPs, size, crystallinity, aggregation, surface properties and interaction with 89 
inorganic or organic supports can alter their catalytic properties (Gawande et al., 2016; Deka 90 
et al., 2019) and toxicity (Hou et al., 2017; Ameh et al., 2019). However, the influence of 91 
CuNPs’ morphology and surface modification by association with other molecules on 92 
reproductive processes has not been studied yet. 93 
Due to our ongoing interest on transition-metal nanoparticles (Alonso et al., 2008), we have 94 
studied the catalytic activity of both unsupported (Abdulkin et al., 2013) and supported 95 
CuNPs on different inorganic supports, such as activated charcoal (Mitrofanov et al., 2017), 96 
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zeolite Y (Alonso et al., 2015) and titania (Martín-García et al, 2018). We want to present 97 
herein a study to unveil (1) whether CuNPs can or cannot directly affect basic ovarian cell 98 
functions, (2) any possible effect of the morphology on the CuNPs’ performance, and (3) the 99 
impact of the support on the CuNPs’ activity. For this purpose, we have compared the 100 
influence of CuNPs of similar size but different shape (spherical, triangular, hexagonal) and 101 
that of spherical CuNPs supported on titania (CuNPs/TiO2), zeolite Y (CuNPs/ZY) and 102 
activated charcoal (CuNPs/C) on the viability, proliferation, apoptosis and release of 103 
progesterone, testosterone and 17β-estradiol by cultured porcine ovarian granulosa cells. We 104 
have compared the dose-dependent action of these six types of CuNPs on cell viability, the 105 
accumulation of Bcl-2-associated X protein (bax, a marker of cytoplasmic apoptosis) (Peña-106 
Blanco and García-Sáez, 2017), accumulation of proliferating cell nuclear antigen (PCNA, a 107 
proliferation marker) (Wang, 2014). In addition, we examined the influence of the CuNPs 108 
support on the secretory activity of ovarian cells. For this purpose, we analyzed the influence 109 
of CuNPs/TiO2, CuNPs/ZY and CuNPs/C, added at different doses, on the release of the 110 
steroid hormones progesterone, testosterone and 17-estradiol, the markers and regulators of 111 
ovarian cell functions (Sirotkin, 2014). Such a study has not been performed previously. It 112 
could be important for understanding the character and mechanisms of CuNPs’ action, to 113 
search for factors affecting the biological activity of CuNPs, as well as to search for CuNPs 114 
that are suitable for therapeutic applications with minimal toxic side-effects.  115 
 116 
2. MATERIALS AND METHODS 117 
See the supporting information for general experimental information and nanoparticle 118 




Preparation of unsupported copper nanoparticles 121 
The syntheses of triangular and hexagonal CuNPs were carried out following the general 122 
procedure described by Carpenter’s group (Carrol et al., 2011). This procedure involves the 123 
preparation of a 0.1 M solution of copper(II) chloride (CuCl2) in the corresponding polyol 124 
(propylene glycol for triangular and diethylene glycol for hexagonal CuNPs), followed by the 125 
addition of NaOH (0.3 M) and reflux for 2 h. The resulting suspension was diluted with water 126 
at 50%. The obtained monodispersed CuNPs showed an average size of 1.27±0.37 and 127 
1.81±0.52 nm for triangular (Fig. 1A) and hexagonal CuNPs (Fig. 1B), respectively. 128 
Spherical CuNPs were prepared following the methodology of Alonso’s group (Alonso et al., 129 
2008). In a typical procedure, anhydrous CuCl2 (97%, Aldrich; 134 mg, 1.0 mmol) was added 130 
to a suspension of lithium powder (Medalchemy S.L.; 14 mg, 2.0 mmol) and 4,4′-di-tert-131 
butylbiphenyl (DTBB, Sigma-Aldrich; 27 mg, 0.1 mmol) in dry THF (20 mL) at room 132 
temperature under argon. The reaction mixture, which was initially dark green, changed to 133 
black, indicating that the suspension of CuNPs was formed. From this suspension, a 1.9 mL 134 
sample was diluted with deionized water (10 mL). Spherical CuNPs with an average size of 135 
2.88±0.94 nm were obtained (Fig. 2). 136 
 137 
Preparation of supported copper nanoparticles 138 
The supported CuNPs were synthesized following the same methodology as above but, in this 139 
case, the black suspension was diluted with dry THF (18 mL) followed by the addition of the 140 
corresponding inorganic support (1.28 g): sodium Y zeolite (Sigma-Aldrich), activated 141 
charcoal (Norit CA1, Sigma-Aldrich) or TiO2 (anatasa nanopowder, Alfa Aesar). Then, the 142 
resulting mixture was stirred for 1 h at room temperature, filtered, and the obtained solid was 143 
dried under air (TiO2) or vacuum (zeolite Y and activated charcoal). 144 
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The materials showed monodispersed spherical CuNPs of average size 0.98±0.42 nm for TiO2 145 
(Mitrofanov et al., 2017) and 1.71±0.35 nm for zeolite Y (Alonso et al., 2015), and of 146 
5.95±0.95 nm for activated charcoal (Alonso et al., 2011) (Fig. 2). The copper loading in 147 
these materials was determined by inductively coupled plasma optical emission spectroscopy 148 
(ICP-OES), being 1.9, 3.0 and 3.5 wt% for TiO2, zeolite Y and activated charcoal, 149 
respectively. 150 
It must be mentioned that both the unsupported and supported CuNPs are obtained as a 151 
mixture of Cu(I) and Cu(II) oxides due to exposure to air. 152 
The characteristics of the unsupported and supported CuNPs and the methods used for their 153 
characterization are described in the Supporting information file. 154 
Isolation and culture of granulosa cells 155 
Ovaries at the follicular phase of the ovarian cycle of non-cycling pubertal gilts, 156 
approximately 180 days’ age, were obtained after slaughter at a local slaughterhouse and 157 
processed as described previously elsewhere (Roychoudhury et al., 2014; Sirotkin et al., 158 
2015). The collected granulosa cells at a final concentration of 106 cells/mL were cultured in 159 
sterile DMEM/F12 1:1 medium supplemented with 10% fetal calf serum (both from 160 
BioWhittakerTM, Verviers, Belgium) and 1% antibiotic-antimycotic solution (Sigma, St. 161 
Louis, MO, USA) in 16-well (200 µL/well) chamber slides (Nunc Inc., International, 162 
Naperville, USA). After 3–4 days’ pre-culture, the medium (of the same composition as 163 
above) was renewed, and the cells were cultured for 2 days in the medium with and without 164 
the CuNPs listed above at the concentrations of 0, 1, 10 or 100 ng/mL. These are typical 165 
CuNPs concentrations that have been tested in previous animal in-vivo and in-vitro 166 
experiments (Liu et al., 2016; C A et al., 2018; Noureen et al., 2018; Sutunkova et al., 2018). 167 
After two days of culture, the cells were washed with ice-cold PBS (pH 7.5), fixed in 168 
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paraformaldehyde (4% in PBS, pH 7.2–7.4; 60 min) and kept at 4 °C until 169 
immunocytochemical analysis. The culture medium was frozen at –17 oC to await RIA. 170 
The nanoparticles were dispersed by gentle pipetting in the culture medium during 1 min, up 171 
to a concentration of 100 ng/mL, immediately before the addition to the cells. 172 
Cell-viability test 173 
Cell viability was evaluated by using the Trypan blue exclusion test, according to Strober 174 
(2001). Briefly, the medium from the culture plates was removed after incubation of the 175 
granulosa cells. Subsequently, the cell monolayer was subjected to Trypan blue staining 176 
(Sigma Aldrich, Hamburg, Germany) for 15 min. Following removal of this dye, the plates 177 
were washed twice with physiological solution and subjected to microscopic inspection 178 
(magnification: 400×). The ratio of dead (stained) cells to total cell count was calculated. 179 
Immunocytochemical analysis of proliferation and apoptosis markers 180 
The presence of PCNA and bax in the cells was detected by immunocytochemistry, as 181 
described previously elsewhere (Roychoudhury et al., 2014; Sirotkin et al., 2015), by using 182 
primary monoclonal antibodies against these molecules (all from Santa Cruz Biotechnology, 183 
Inc., Santa Cruz, USA). They were placed in either, a dilution of 1:500 in PBS secondary 184 
swine antibodies against mouse IgG labeled with horseradish peroxidase (Servac, Prague, 185 
Czech Republic, dilution of 1:1000) and visualized by staining with DAB-substrate (Roche 186 
Diagnostics GmbH, Manheim, Germany), or by secondary polyclonal goat antibodies against 187 
mouse IgGs labeled with the fluorescent marker fluorescein isothiocyanate (FITC; Santa Cruz 188 
Biotechnology, dilution 1:1000). The presence of molecules in the cells was determined using 189 
a light and fluorescence microscope (Leica GmbH, Wetzlar, Germany). Cells processed 190 
without the primary or secondary antibody were used as the negative controls. The cells 191 
expressing a signal greater than the background negative control levels were considered 192 
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positive. The proportion of cells containing visible molecules relative to the total cell number 193 
was calculated.  194 
Immunoassay of hormones 195 
Concentrations of progesterone, testosterone and 17β-estradiol were determined in 25 µL 196 
aliquots of incubation medium by the enzyme-linked immunosorbent assay (ELISA). 197 
Hormones were assayed using ELISA’s kits according to the manufacturer’s instructions 198 
(LDN Immunoassays and Services, Nodhorn, Germany).  199 
Antiserum against progesterone cross-reacted ≤1.1% with 11-desoxycorticosterone, ≤0.35% 200 
with pregnenolone, ≤0.30% with 17α-hydroxyprogesterone, ≤0.20% with corticosterone, 201 
˂0.10% with estriol, 17β-estradiol, testosterone, cortisone and 11-desoxycortisol, ˂0.02% 202 
with DHEA-S and cortisol. The sensitivity of the assay was 0.045 ng/mL. Intra- and inter-203 
assay coefficients of variation did not exceed 5.40% and 5.59%, respectively. 204 
The cross-reactivity of antiserum against testosterone was ≤3.3% with 11β-205 
hydroxytestosterone and 19-nortestosterone, ≤0.9% with androstenedione, ≤0.8% with 5α-206 
dihydrotestosterone, ˂0.1% with 17α-methyltestosterone, epitestosterone, E, P, cortisol, 207 
estrone and danazol. The maximal intra- and inter-assay coefficients of variation were 4.16% 208 
and 4.73%, respectively. Sensitivity of the assay was 0.083 ng/mL. 209 
The sensitivity of the 17β-estradiol assay was 6.2 pg/mL. Intra- and inter-assay coefficients of 210 
variation did not exceed 6.4% and 4.5%, respectively. The cross-reactivity of antiserum 211 
against 17β-estradiol was ≤9.5% with fulvestrant, ≤4.2% with estrone, ≤3.8% with E2-3-212 
glucuronide, ≤3.6% with E2-3-sulphate, ≤0.4% with estriol, ˂0.1% with androstenedione, 213 
17α-hydroxyprogesterone, corticosterone, pregnenolone, E2-17-glucuronide, progesterone 214 
and testosterone. 215 
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All ELISA assays were validated for culture medium samples by dilution tests. 216 
 217 
Statistical analysis 218 
Each experiment was repeated three times using different animals (10–15 gilts per 219 
experiment). Each experimental group was represented by four chamber-slide wells. By RIA, 220 
blank control values were subtracted from the value determined in cell-conditioned serum-221 
supplemented medium to exclude any non-specific background (less than 13% of the total 222 
values). Secretion rates were calculated per 106 cells/day or mg tissue/day. Differences 223 
between groups were evaluated using the Shapiro-Wilk’s normality and Student’s t-tests and 224 
Sigma Plot 11.0 (Systat Software, GmbH, Erkhart, Germany). Values are presented as the 225 
mean ± S.D. Differences were compared for statistical significance at P-levels less than 0.05 226 
(P < 0.05). 227 
3. RESULTS 228 
The different types of nanoparticles tested in this study were prepared according to literature 229 
methods. In particular, spherical unsupported CuNPs (2.88±0.94 nm) were prepared by 230 
chemical reduction of copper(II) chloride with metal lithium as previously reported by us 231 
(Alonso et al., 2008), whereas triangular and hexagonal unsupported CuNPs were obtained by 232 
the polyol method following the general protocol by Carpenter’s group (Carrol et al., 2011) 233 
(Fig. 1). It is noteworthy that the size of the triangular (1.27±0.37 nm) and hexagonal 234 
(1.81±0.52 nm) CuNPs decreased abruptly upon the addition of water, when compared with 235 
that observed by Carpenter’s group for dried samples (ca. 50 nm) (Fig. 1). A common feature 236 
to all the unsupported CuNPs was their trend to grow by coalescence in the aqueous solution 237 
upon prolonged exposure to TEM irradiation. This behavior had a more pronounced effect in 238 
the triangular and hexagonal CuNPs, where the edges were rapidly blurred and the original 239 
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shape was more difficult to identify. Nevertheless, we have highlighted in Fig. 1B and 1C the 240 
shape of some of the mentioned CuNPs. The supported CuNPs were obtained by the 241 
aforementioned method of reduction of copper(II) chloride with metal lithium, followed by 242 
the addition of the inorganic support (titania, zeolite Y or activated charcoal) with stirring, 243 
filtration and drying. All supported CuNPs were spherical, being relatively small and 244 
monodispersed for those on titania (0.98±0.42 nm) and zeolite Y (1.71±0.35 nm), and larger 245 
for those on activated charcoal (5.95±0.95 nm) (Fig. 2). The CuNPs on titania (CuNPs/TiO2, 246 
Fig. 2A) can be visually distinguished as very tiny spots on the larger but nanosized particles 247 
of the support (titania anatase nanopowder), whereas there is a sharp contrast between the 248 
CuNPs (foreground) and the zeolite Y support (background) (CuNPs/ZY, Fig. 2B). CuNPs 249 
are clearly observable as black spots on a grey charcoal background (CuNPs/C, Fig. 2C). 250 
The comparison of spherical, triangular, hexagonal and spherical CuNPs/TiO2, CuNPs/ZY 251 
and CuNPs/C showed substantial differences in their action on ovarian cell viability, 252 
proliferation, apoptosis and release of progesterone, testosterone and 17β-estradiol.  253 
Both spherical (Fig. 3A) and triangular (Fig. 3B) CuNPs raised cell viability at all the doses 254 
added. On the contrary, hexagonal CuNPs decreased the viability of cells when added at doses 255 
of 10 and 100 ng/mL (Fig. 3C). Spherical CuNPs/TiO2 (Fig. 3D), CuNPs/ZY (Fig. 3E) and 256 
CuNPs/C (Fig. 3F) triggered cell viability at doses of 10 and 100 ng/mL, 10 and 100 ng/mL 257 
and 100 ng/mL, respectively. 258 
Spherical CuNPs lowered PCNA accumulation in the cells when added at doses of 1 or 10 259 
ng/mL (Fig. 4A). Triangular CuNPs enhanced accumulation of this proliferation marker at all 260 
the doses added (Fig. 4B), whereas the hexagonal counterparts inhibited PCNA accumulation 261 
at all the doses added (Fig. 4C). CuNPs/TiO2 reduced it at doses of 10 and 100 ng/mL (Fig. 262 
4D), whilst CuNPs/ZY (Fig. 4E) and CuNPs/C (Fig. 4F) increased PCNA accumulation when 263 
added at all the doses or at 100 ng/mL, respectively. 264 
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Bax accumulation in the ovarian cells was suppressed by spherical CuNPs (at doses of 10 or 265 
100 ng/mL, Fig. 5A) and triangular (at 100 ng/mL, Fig. 5B) but not by hexagonal ones (Fig. 266 
5C). Spherical CuNPs/TiO2 reduced bax accumulation at all the doses added (Fig. 5D). 267 
Conversely, when supported on zeolite Y, spherical CuNPs (at 1 or 10 ng/mL) resulted in 268 
significant promotion of bax accumulation (Fig. 5E). Bax accumulation fell at a dose of 100 269 
ng/mL for CuNPs/C (Fig. 5F). 270 
The analysis of progesterone release by cells cultured with CuNPs showed a drop in the 271 
progesterone output under the influence of CuNPs/TiO2 (at all the doses added, Fig. 6A), but 272 
not under that of CuNPs/ZY (Fig. 6B). For CuNPs/C, as opposed to CuNPs/TiO2, 273 
progesterone release was intensified at all the doses (Fig. 6C), whereas CuNPs/C at the 274 
highest dose (100 ng/mL) was less effective than at lower doses (1 or 10 ng/mL) (Fig. 6C). 275 
T release was suppressed by CuNPs/TiO2 (at all doses added) (Fig. 7A) but boosted by 276 
CuNPs/ZY (at 100 ng/mL, Fig. 7B) and CuNPs/C (at 10 and 100 ng/mL, Fig. 7C) in a dose-277 
dependent manner. 278 
Similar to the testosterone release, the 17β-estradiol output was reduced by CuNPs/TiO2 (at 279 
10 or 100 ng/mL, Fig. 8A) but rose by CuNPs/ZY (Fig. 8B) and CuNPs/C (Fig. 8C) at all the 280 
doses added. The effects of CuNPs/ZY and CuNPs/C on 17β-estradiol release have a dose-281 
dependent character too. 282 
 283 
DISCUSSION 284 
The creation of a monolayer, high cell viability, presence of proliferation marker PCNA and 285 
production of steroid hormones indicate that the tested porcine granulosa cells were in good 286 
condition and suitable for analysis and testing of both the negative and positive behavior of 287 
CuNPs when given at physiological doses (Liu et al., 2016; C A et al., 2018; Noureen et al., 288 
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2018; Sutunkova et al., 2018). Furthermore, the present observations demonstrate CuNPs 289 
directly affecting ovarian cells and their basic functions – viability, proliferation, apoptosis 290 
and release of hormones. These parameters are considered as both markers and regulators of 291 
ovarian functions and fecundity (Sirotkin, 2014). Additionally, the CuNPs’ action on these 292 
parameters observed in our experiments, together with the previous reports (Fevold et al., 293 
1936; Roychoudhury et al., 2014, 2016; Yang et al., 2017; Zhang et al., 2018), denote a 294 
CuNPs-triggered change on female reproductive functions, including fecundity. Moreover, 295 
they demonstrate that CuNPs can govern female reproductive processes, directly affecting 296 
various ovarian cell functions. Finally, comparison of the CuNPs performance on various 297 
read-outs points out the different role of CuNPs on female reproduction and their 298 
mechanisms. For example, they mean that most of the CuNPs tested in our experiments are 299 
not toxic. On the contrary, they can augment ovarian cell viability; only hexagonal CuNPs 300 
diminished it. Cell viability is defined by the balance between cell proliferation and 301 
apoptosis/death. The comparison of the CuNPs repercussion on PCNA and bax suggests that 302 
the gain of the cell viability under the CuNPs influence can be mainly due to suppression of 303 
cell apoptosis. In addition, triangular CuNPs and spherical CuNPs/C could raise cell viability 304 
also by promotion of cell proliferation. Finally, CuNPs/ZY could increment cell viability 305 
because they stimulated proliferation more than apoptosis. The adverse outcome for 306 
hexagonal CuNPs on cell viability can be explained by its ability to reduce cell proliferation 307 
without change in their apoptosis. On the other hand, we cannot exclude that cell viability can 308 
be defined not only by the PCNA/bax rate, but also by other regulators of cell proliferation 309 
and death (Pérez-Garijo and Steller, 2015; Fritsch et al., 2017; Gudipaty et al., 2018). 310 
The CuNPs’ action on cell proliferation and apoptosis can be mediated, in turn, by the role of 311 
CuNPs on the release of steroid hormones: the known auto-, para- and endocrine regulators of 312 
ovarian cell proliferation and apoptosis, ovarian follicullogenesis and resulted fecundity 313 
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(Sirotkin, 2014). The activity of supported CuNPs on three different supports was studied for 314 
progesterone, testosterone and 17-estradiol release by ovarian cells. CuNPs/TiO2 suppressed 315 
the release of these steroid hormones; opposite to this behavior, CuNPs/ZY and CuNPs/C 316 
mainly triggered the aforementioned release in a dose-dependent manner. The bell-shape 317 
effect of CuNPs/C on the progesterone output can be explained by the existence of adaptive 318 
negative feedback mechanisms preventing overstimulation of ovarian progesterone release, 319 
which could induce premature luteinization and suppression of ovarian follicullogenesis 320 
(Sirotkin, 2014). Both, stimulation and inhibition of the estrogen output can be explained by 321 
the corresponding changes in its precursors – testosterone and progesterone (Sirotkin, 2014). 322 
Further to this, 17-estradiol is a known promoter of ovarian cell proliferation and inhibitor of 323 
cell apoptosis what, in turn, stimulates ovarian follicle growth and suppresses cell atresia 324 
(Sirotkin, 2014). Therefore, it is possible that the promotion of ovarian cell viability and 325 
proliferation by CuNPs/ZY, and the apoptosis inhibition by CuNPs/C could be explained by 326 
their capacity to foster ovarian steroidogenesis. The inhibition of cell proliferation and 327 
apoptosis, and the increase in cell viability by CuNPs/TiO2 can be explained by the 328 
suppression of the steroid hormones release. 329 
Our research is, probably, the first demonstration that the character of the CuNPs’ action on 330 
reproductive functions can be defined by the morphology and support of the CuNPs. 331 
Understanding how the shape and support of CuNPs control their activity requires further 332 
studies. Nevertheless, it might be hypothesized that the CuNPs’ properties can modify their 333 
capability to enter cellular membranes and affect the Ca2+ influx into the cells, intracellular 334 
protein kinases and transcription factors, metabolic and anti-oxidative enzymes, and the 335 
production of reactive oxygen species resulting in DNA damage (Hou et al., 2017; Yang et 336 
al., 2017; Pohanka, 2019). The differences in these characteristics could be possible causes of 337 
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inconsistency of the available reports concerning the type of consequences of CuNPs on the 338 
reproductive system and mentioned in the introduction. 339 
Notwithstanding the limitation to rationalize the obtained results, it is worthwhile mentioning 340 
the distinctive behavior observed for hexagonal CuNPs: these nanoparticles are the only ones 341 
that reduce the ovarian cell viability and proliferation, inhibiting PCNA accumulation. It is 342 
known that the presence of vertices makes metal nanoparticles more reactive. Although this 343 
might be one reason of this particular behavior, the fact that the nanoparticles have been 344 
prepared in the presence of the somewhat toxic diethylene glycol must not be disregarded. As 345 
regards hormone release, the support seems to exert an outstanding role as only CuNPs/TiO2 346 
depletes or suppresses this function. Anatasa titania is composed of chains of distorted TiO6 347 
octahedra possessing undercoordinated atoms at the most abundant nanocrystal faces: i.e., 4- 348 
or 5-fold instead of 6-fold-coordinated Ti atoms, as well as 2-fold instead of 3-fold-349 
coordinated O atoms (Bourikas et al., 2014); this makes titania particularly reactive. It is 350 
known that oxygen-containing molecules, such as water, can bind 5-fold-coordinated Ti 351 
atoms (through the water oxygen) and 2-fold-coordinated O atoms (through the water 352 
hydrogens). Therefore, an interaction of titania with the oxygen atoms of the three hormones 353 
or their precursors (more enhanced in the case of testosterone and 17-estradiol because of 354 
the presence of hydroxyl groups in their structure) cannot be ruled out and might account for 355 
the particular effect observed for CuNPs/TiO2 on hormone release. 356 
From the practical viewpoint, the present investigation hints that several CuNPs cannot 357 
damage/suppress ovarian cell functions but even facilitate their viability, proliferation and 358 
secretory activity, suppressing their apoptosis. The lack of a visible toxic effect indicates the 359 
safety of their application, at least for reproductive health, although hexagonal CuNPs can be 360 
toxic (see below). Moreover, the potential utility of the stimulatory properties of CuNPs for 361 
the improvement of reproductive processes cannot be overruled. However, it must be taken 362 
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into account that the stimulatory properties of CuNPs resemble some signs of malignant 363 
transformation of ovarian cells, which are characterized just by these changes (Minorics and 364 
Zupko, 2018; Sharma et al., 2019). Therefore, the efficiency of CuNPs to induce such 365 
transformations should be carefully checked before application. On the other hand, the 366 
inhibitory action of hexagonal CuNPs on ovarian cell functions (reduction of cell viability and 367 
proliferation) illustrates a potential adverse consequence on female reproduction, as well as a 368 
potential usefulness for inhibition of reproductive processes or ovarian cancer. These 369 
indications should be, however, examined through both animal and human in-vivo 370 
experiments, including careful examination of possible toxic and stimulatory effects of 371 
CuNPs, given at the appropriate doses on both reproductive and non-reproductive systems.  372 
Nevertheless, our present observations could be helpful for the generation and application of 373 
CuNPs with desirable biological effects in veterinary and human medicine, and for the 374 
production of safe CuNPs-containing products. 375 
Taken together, our observations confirm the direct, mainly stimulatory, impact of CuNPs on 376 
ovarian cells and their ability to affect their viability, proliferation, apoptosis and steroid 377 
hormones release. Furthermore, to the best of our knowledge, this represents the first 378 
demonstration that the nature of the CuNPs’ action depends on their shape (spherical, 379 
triangular, hexagonal) and support (zeolite Y, TiO2 or activated charcoal). Therefore, CuNPs 380 
with appropriate chemical modification could be potentially useful to control reproductive 381 
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FIGURES AND LEGENDS 595 
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Figure 1. Transmission electron microscopy micrographs of spherical (A), triangular (B) and 598 








     602 
Figure 2. Transmission electron microscopy micrographs of supported CuNPs/TiO2 (A), 603 






Figure 3. Comparison of the effect of spherical (A), triangular (B), hexagonal (C) CuNPs, 606 
and spherical CuNPs/TiO2 (D), CuNPs/ZY (E) and CuNPs/C (F), added at the doses of 0, 1, 607 
10 or 100 ng/mL medium, on viability (measured by the Trypan blue extrusion test) of 608 
cultured porcine ovarian granulosa cells. Each experiment was repeated three times using 609 
different animals. Each experimental group was represented by four chamber-slide wells (n = 610 
12). Values are presented as the mean ± S.D.; the asterisk indicates the effect of treatment – 611 
significant (P < 0.05) differences between cells treated versus untreated (dose 0 ng/mL) with 612 
nanoparticles. 613 
A B C 




Figure 4. Comparison of the effect of spherical (A), triangular (B), hexagonal (C) CuNPs, 615 
and spherical CuNPs/TiO2 (D), CuNPs/ZY (E) and CuNPs/C (F), added at the doses of 0, 1, 616 
10 or 100 ng/mL medium, on proliferation (accumulation of PCNA measured by quantitative 617 
immunocytochemistry) of cultured porcine ovarian granulosa cells. Each experiment was 618 
repeated three times using different animals. Each experimental group was represented by 619 
four chamber-slide wells (n = 12). Values are presented as the mean ± S.D.; the asterisk 620 
indicates the effect of treatment – significant (P < 0.05) differences between cells treated 621 
versus untreated (dose 0 ng/mL) with nanoparticles. 622 
A B C 




Figure 5. Comparison of the effect of spherical (A), triangular (B), hexagonal (C) CuNPs, 624 
and spherical CuNPs/TiO2 (D), CuNPs/ZY (E) and CuNPs/C (F), added at the doses of 0, 1, 625 
10 or 100 ng/mL medium on apoptosis (accumulation of bax measured by quantitative 626 
immunocytochemistry) by cultured porcine ovarian granulosa cells. Each experiment was 627 
repeated three times using different animals. Each experimental group was represented by 628 
four chamber-slide wells (n = 12). Values are presented as the mean ± S.D.; the asterisk 629 
indicates the effect of treatment – significant (P < 0.05) differences between cells treated 630 







Figure 6. Comparison of the effect of spherical CuNPs/TiO2 (A), CuNPs/ZY (B) and 636 
CuNPs/C (C), added at the doses of 0, 1, 10 or 100 ng/mL medium on the release of 637 
progesterone (measured by ELISA) by cultured porcine ovarian granulosa cells. Each 638 
experiment was repeated three times using different animals. Each experimental group was 639 
represented by four chamber-slide wells (n = 12). Values are presented as the mean ± S.D.; 640 
the asterisk indicates the effect of treatment – significant (P < 0.05) differences between cells 641 
treated versus untreated (dose 0 ng/mL) with nanoparticles. 642 
 643 
Figure 7. Comparison of the effect of spherical CuNPs/TiO2 (A), CuNPs/ZY (B) and 644 
CuNPs/C (C), added at the doses of 0, 1, 10 or 100 ng/mL medium on the release of 645 
testosterone (measured by ELISA) by cultured porcine ovarian granulosa cells. Each 646 
experiment was repeated three times using different animals. Each experimental group was 647 
represented by four chamber-slide wells (n = 12). Values are presented as the mean ± S.D.; 648 
the asterisk indicates the effect of treatment – significant (P < 0.05) differences between cells 649 
treated versus untreated (dose 0 ng/mL) with nanoparticles. 650 
A B C 




Figure 8. Comparison of the effect of spherical CuNPs/TiO2 (A), CuNPs/ZY (B) and 652 
CuNPs/C (C), added at the doses of 0, 1, 10 or 100 ng/mL medium on the release of 17β-653 
estradiol (measured by ELISA) by cultured porcine ovarian granulosa cells. Each experiment 654 
was repeated three times using different animals. Each experimental group was represented by 655 
four chamber-slide wells (n = 12). Values are presented as the mean ± S.D.; the asterisk 656 
indicates the effect of treatment – significant (P < 0.05) differences between cells treated 657 
versus untreated (dose 0 ng/mL) with nanoparticles. 658 
A B C 
